Race Oncology Ltd. ( ($AU:RAC) ) has issued an announcement. Race Oncology announced the successful and safe dosing of the first patient with a ...

A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and ...

A new biotech has come roaring to life in Wales with a $140 million series A and a lead candidate ready for phase 2 trials in ...

The Al Dibdibah Power and Al Shagaya Renewable Energy Phase III Zone I solar project will be built at the Shagaya Renewable Energy Park in Jahra Governorate, located west of Kuwait City.

The contract covers the operation readiness phase before first oil as well as the operations and maintenance services for a minimum of 2 years after first oil with extension ...

The trial is being carried out in 16 nations and regions, including Asia, North America, Europe, and South America.

The decision to move into phase 3 testing follows the completion of various phase 1 studies that backed the drug's safety, tolerability, and pharmacokinetics, according to Roche. The drug ...

Buoyed by new results from a phase 1b/2a trial ... It has been found that less than 1% of some anti-amyloid antibodies end up in the CNS where they can exert their activity, but Roche has ...